Does INTERPACE BIOSCIENCES, INC. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores INTERPACE BIOSCIENCES, INC. (IDXG) 49.3 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 73, returns on capital 9, balance-sheet safety 100, capital discipline 24.

Is IDXG stock trading below its intrinsic value?

Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $6.30 per share versus a recent price of $1.42 — 77% below value. This is an educational estimate computed from primary SEC filings, not investment advice.

How has IDXG's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 49.3 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

INTERPACE BIOSCIENCES, INC.

IDXG · Healthcare · $6.3M mkt cap · FY2025 filings · Shallow moat ·

On the watchlist

Shallow moat

The four filters

Pricing power73

Median gross margin 55.2% over 10y, variable.

Returns on capital9

Median ROIC -72.5%, above the 9% hurdle in 25% of years.

Balance-sheet safety100

Net cash position — no leverage risk.

Capital discipline24

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale

77% below value

Owner earnings (normalized): $2.5M
Est. intrinsic value / share: $6.30
Recent price: $1.42
Discount to value: 77% below value

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for IDXG yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale49.3 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — IDXG has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#119 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#117STAA STAAR SURGICAL CO49.5 out of 100, Shallow moatShallow moat
#118BRTX BIORESTORATIVE THERAPIES, INC.49.5 out of 100, Shallow moatShallow moat
#120BIO Bio-Rad Laboratories, Inc.49.0 out of 100, Shallow moatShallow moat
#121VASO VASO CORPORATION49.0 out of 100, Shallow moatShallow moat

Compare IDXG with its nearest peers →All Healthcare companies on the Index →

Common questions about IDXG

Does INTERPACE BIOSCIENCES, INC. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores INTERPACE BIOSCIENCES, INC. (IDXG) 49.3 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 73, returns on capital 9, balance-sheet safety 100, capital discipline 24.
Is IDXG stock trading below its intrinsic value?: Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $6.30 per share versus a recent price of $1.42 — 77% below value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has IDXG's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 49.3 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows IDXG’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/IDXG"
  width="340" height="150" style="border:0"
  title="IDXG Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell IDXG. See the disclaimer.